Laverdia-CA1 Tablets

LAVERDIA®-CA1 is the first oral tablet FDA conditionally approved to treat lymphoma in dogs.

​LAVERDIA®-CA1 is conditionally approved by FDA pending a full demonstration of effectiveness under application number 141-526.

1 bottle = 50 count